Scholars Central

Mini reviewPublished 27 Oct 2022

Brown Adipose Tissue Activation Nutraceuticals

Authors: Stefania Lombardo

Medicinal Chemistry

Volume 12 · Issue 10 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Obesity and its comorbidities have become pandemic, posing a challenge to the global healthcare system. To address such a public health burden, lifestyle changes, nutritional interventions, and pharmaceuticals should be combined in a personalised strategy. Obesity and glucose metabolism dysfunctions are exacerbated by altered brown adipose tissue function. Through uncoupled respiration, BAT thermogenic activity burns glucose and fatty acids to produce heat, which can dissipate excess calorie intake, reduce glycemia, and circulate fatty acids released from white adipose tissue. Thus, BAT activity is expected to contribute to overall energy homeostasis and protect against obesity, diabetes, and lipid profile changes. To date, clinical trials for pharmacological therapies aimed at activating brown fat have failed due to cardiovascular side effects or insufficient efficacy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Medicinal Chemistry.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedicinal Chemistry
  • SubjectChemistry
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Stefania Lombardo”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels